| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,250,000,000 |
| Market
Cap: |
93.40(B) |
| Last
Volume: |
17,428,744 |
Avg
Vol: |
12,037,980 |
| 52
Week Range: |
$40.25 - $65.3 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 97 |
| Guru Rank Value : 8.6 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
13,571 |
13,571 |
| Total Buy Value |
$0 |
$0 |
$672,994 |
$672,994 |
| Total People Bought |
0 |
0 |
2 |
2 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
18,718 |
616,397 |
| Total Sell Value |
$0 |
$0 |
$1,146,397 |
$44,859,834 |
| Total People Sold |
0 |
0 |
2 |
5 |
| Total Sell Transactions |
0 |
0 |
2 |
11 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cuss Francis M |
EVP & CSO |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,802 |
264,739 |
|
- |
|
| Cuss Francis M |
EVP & CSO |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,009 |
261,937 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-06 |
4 |
D |
$65.12 |
$363,435 |
D/D |
(5,581) |
298,578 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,189 |
304,159 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,573 |
298,970 |
|
- |
|
| Nielsen Anne |
Chief Compliance & Ethics Off |
• – – |
2015-03-06 |
4 |
D |
$65.12 |
$37,704 |
D/D |
(579) |
48,726 |
|
- |
|
| Nielsen Anne |
Chief Compliance & Ethics Off |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
674 |
49,305 |
|
- |
|
| Nielsen Anne |
Chief Compliance & Ethics Off |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
724 |
48,631 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-06 |
4 |
D |
$65.12 |
$414,619 |
D/D |
(6,367) |
171,702 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
6,818 |
178,069 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,323 |
171,251 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$147,713 |
D/D |
(2,371) |
41,516 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,182 |
43,887 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,182 |
40,705 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$400,776 |
D/D |
(6,433) |
111,330 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,747 |
117,763 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,747 |
108,016 |
|
- |
|
| Cuss Francis M |
EVP & CSO |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$171,886 |
D/D |
(2,759) |
246,302 |
|
- |
|
| Cuss Francis M |
EVP & CSO |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,703 |
249,061 |
|
- |
|
| Cuss Francis M |
EVP & CSO |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,703 |
245,358 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$409,623 |
D/D |
(6,575) |
272,171 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,418 |
278,746 |
|
- |
|
| Leung Sandra |
General Counsel & Secretary |
• – – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,418 |
271,328 |
|
- |
|
| Elicker John E |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
D |
$62.30 |
$51,584 |
D/D |
(828) |
52,359 |
|
- |
|
| Elicker John E |
SVP Pub Affairs & Inv Relation |
• – – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,360 |
53,187 |
|
- |
|
956 Records found
|
|
Page 35 of 39 |
|
|
0.99 (2.33%) 
